Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 25,75€(−18,54%). Der Median liegt bei 25,98€(−17,81%).
Kaufen | 7 |
Halten | 5 |
Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Trade, Schmade. Switch to T-Mobile.
BELLEVUE, Wash.--(BUSINESS WIRE)--T-Mobile (NASDAQ: TMUS) is making it easier than ever to switch with its best iPhone offer yet. Starting today, the Un-carrier will give you a brand-new iPhone 16 Pro on Us, — no trade-in needed — and cover up to $800 per line to help pay off your current phones from the other guys too. This is a limited time, never been done before, best iPhone deal from T-Mobile ever kinda thing! And it's all available on Experience Beyond — the most value-packed plan in wire.» Mehr auf businesswire.com
T-Mobile Home Internet Launches Spring Savings Offers — Switch and Get Over $1000
BELLEVUE, Wash.--(BUSINESS WIRE)--Ready for a fresh start this spring? Today, T-Mobile (NASDAQ: TMUS) announced new 5G Home Internet offers making it easy and affordable to switch, just in time for moving season, spring cleaning or any occasion, really. Starting tomorrow, April 3, for a limited time, people can: Get up to $1,050 when switching to T-Mobile Home Internet. Customers can get a $300 virtual Mastercard when switching to All-In Internet or a $200 virtual Mastercard when choosing Ampli.» Mehr auf businesswire.com
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
Company to integrate industry leading big data technology solutions into its AI-driven platform to expand capabilities in identifying eligible patients to receive formerly Rx medications over the counter NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-the-counter ("OTC") drug development programs, today announces a collaboration with renowned Big Data and analytics leader to enhance the development of its proprietary technology solutions designed to facilitate Rx-to-OTC switches for pharmaceutical products. The collaboration will incorporate an automated credentialing solution to help improve the Company's identity verification system, which also encompasses an AI component.» Mehr auf accessnewswire.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | 2021 | |
---|---|---|
Umsatz | 520,64 Mio | 23,95% |
Bruttoeinkommen | 221,97 Mio | 16,48% |
Nettoeinkommen | 12,97 Mio | 1,67% |
EBITDA | 204,37 Mio | 160,86% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 0,00€ |
52 Wochen-Hoch/Tief | 30,69€ - 20,63€ |
Dividenden | Nein |
Beta | 0,59 |
KGV (PE Ratio) | 565,38 |
KGWV (PEG Ratio) | 5,65 |
KBV (PB Ratio) | 25,30 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
Switch, Inc. bietet über seine Tochtergesellschaft Switch, Ltd. Colocation-Raum und damit verbundene Dienstleistungen an. Das Unternehmen entwickelt und betreibt Rechenzentren in Nevada, Michigan und Georgia. Das Unternehmen beliefert Technologie- und digitale Medienunternehmen, Finanzinstitute, Regierungsbehörden, Netzwerk- und Telekommunikationsanbieter sowie Cloud-, IT- und Softwareanbieter. Switch, Inc. wurde im Jahr 2000 gegründet und hat seinen Hauptsitz in Las Vegas, Nevada.
Name | SWITCH INC. CL.A DL-,001 |
CEO | Rob Roy |
Sitz | Las Vegas, nevada USA |
Website | |
Industrie | Luft- und Raumfahrt und Verteidigung |
Börsengang | |
Mitarbeiter | 829 |
Ticker Symbole
Börse | Symbol |
---|---|
NYSE | SWCH |
Assets entdecken
Shareholder von SWITCH INC. CL.A DL-,001 investieren auch in folgende Assets